Table 1.
Pseudomonas aeruginosa Isolates (1997–2016) Stratified by Infection Type and Percentage of Isolates With Resistant Phenotypes
| Resistant Phenotypea | Bloodstream Infection (n = 14 539) | Pneumonia in Hospitalized Patients (n = 23 227) | Skin and Skin Structure Infection (n = 9952) | Intra-abdominal Infection (n = 648) | Urinary Tract Infection (n = 2838) | Other Infection (n = 818) | Total(n = 52 022) |
|---|---|---|---|---|---|---|---|
| Multidrug resistant | 23.7% | 27.7% | 21.7% | 19.3% | 23.0% | 19.1% | 24.9% |
| Extensively drug resistant | 17.4% | 19.0% | 15.8% | 12.7% | 16.5% | 12.3% | 17.6% |
| Pan drug resistant | 0.1% | 0.1% | 0.0% | 0.5% | 0.1% | 0.0% | 0.1% |
| Ceftazidime nonsusceptible | 22.0% | 24.7% | 20.1% | 19.1% | 18.4% | 17.2% | 22.5% |
| Meropenem nonsusceptible | 22.3% | 27.1% | 20.6% | 21.9% | 19.2% | 18.1% | 23.9% |
aCriteria as published by European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2018.